10th Tumor Models Summit San Francisco, January 28-29, 2026
Conference
genOway presentation
Event
-
January 22, 2026
genOway's presentation:
🕒 Thursday, January 28-29, 2026 | 9.30 a.m. PST
🎤 Kader Thiam, Sr Vice President & CSO - Discovery, Preclinical Models & Services
Translational assessment of the safety profile of therapeutics in humanized mouse models
- genO-BRGSF-HIS recapitulates key cytokine release syndrome (CRS) features induced by biologics tested in the clinic
- Immune cells are recruited, polarized and activated into the tumor microenvironment in genO-BRGSF-HIS
- genO-BRGSF-HIS enables assessment of both efficacy and safety in a single model
10th Tumor Models Summit San Francisco, January 28-29, 2026
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe